Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis.
about
Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapyAntibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapyFluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipients.A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis.Opportunistic infections after blood and marrow transplantation.Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxisOfloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy.In vitro activity of sparfloxacin (CI-978; AT-4140) against clinical isolates from cancer patients.Effects on oral and intestinal microfloras of norfloxacin and pefloxacin for selective decontamination in bone marrow transplant patientsProspective, randomized, placebo-controlled trial of norfloxacin for the prophylaxis of recurrent urinary tract infection in women.Selective decontamination in neutropenic patients.Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group.Reduction in clinical response to empiric antimicrobial therapy of febrile granulocytopenic patients receiving TMP/SMX infection prophylaxisPrevention of infection during neutropenia.Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and OncolCiprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli.Antibiotic prophylaxis with meropenem after allogeneic stem cell transplantation.General principles of antibiotic therapy.Pharmacokinetics and effects on bowel and throat microflora of oral levofloxacin as antibacterial prophylaxis in neutropenic patients with haematological malignancies.
P2860
Q24203869-82B70EC6-0787-4365-B73F-F6A8FB863D3DQ24245774-2C1A270F-6873-445E-9DC5-D4A7787EF6C2Q30252749-487376F5-73BD-4021-8874-4A1556094BB2Q33750614-A83DBB76-D960-420B-9547-525CE42ACDBAQ34294774-5FE1ED5E-7BD5-439D-9A7F-5031EFF6EF40Q35122694-F5C0D6E6-94C1-4C81-B128-171331ABB55AQ35248092-D5C10FB7-FB99-4D84-8381-D11F130B82C3Q35283144-5BF17815-EEB2-44C5-9D37-4212CD9549C8Q35354413-DFDD0042-597D-424E-B6BF-6CC3070BA3E3Q35566268-2C252BF3-BB89-4A57-97C2-757B00FFAF41Q35611370-9C60E944-C971-47F7-8B52-962CE174EA02Q35810278-087D86B4-B955-418F-8327-E0C16341AF0CQ35816748-5282F6CA-1932-4131-96B8-F6FFAD7EFB80Q36922609-F9ADE694-B392-49AC-A051-0D2793501029Q38081793-926BDFCC-A5EE-4E2D-A912-D9A129A3C6E3Q39220949-7D01D491-89B0-498D-A3CB-8AD317C4319EQ40545174-F0D416FC-1F79-4313-B263-CAF43831F005Q43546296-1F5D1B20-E7F1-47D4-B8F2-DDA94351A2C0Q44750600-C16256E3-B910-4482-B360-38B7C29EADF6
P2860
Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis.
description
1988 nî lūn-bûn
@nan
1988 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Comparison of norfloxacin with ...... reduced gram-negative sepsis.
@ast
Comparison of norfloxacin with ...... reduced gram-negative sepsis.
@en
Comparison of norfloxacin with ...... reduced gram-negative sepsis.
@nl
type
label
Comparison of norfloxacin with ...... reduced gram-negative sepsis.
@ast
Comparison of norfloxacin with ...... reduced gram-negative sepsis.
@en
Comparison of norfloxacin with ...... reduced gram-negative sepsis.
@nl
prefLabel
Comparison of norfloxacin with ...... reduced gram-negative sepsis.
@ast
Comparison of norfloxacin with ...... reduced gram-negative sepsis.
@en
Comparison of norfloxacin with ...... reduced gram-negative sepsis.
@nl
P2093
P1476
Comparison of norfloxacin with ...... reduced gram-negative sepsis.
@en
P2093
P304
P356
10.1016/0002-9343(88)90062-9
P407
P577
1988-05-01T00:00:00Z